Your browser is no longer supported. Please, upgrade your browser.
NEOG [NASD]
Neogen Corporation
Index- P/E71.46 EPS (ttm)0.58 Insider Own0.10% Shs Outstand107.49M Perf Week0.76%
Market Cap4.46B Forward P/E55.10 EPS next Y0.75 Insider Trans-20.04% Shs Float107.11M Perf Month2.49%
Income62.10M PEG7.15 EPS next Q0.17 Inst Own95.30% Short Float2.68% Perf Quarter-7.13%
Sales487.40M P/S9.15 EPS this Y1.00% Inst Trans-0.06% Short Ratio9.69 Perf Half Y-13.33%
Book/sh7.96 P/B5.17 EPS next Y12.84% ROA6.90% Target Price55.00 Perf Year18.09%
Cash/sh3.70 P/C11.13 EPS next 5Y10.00% ROE7.60% 52W Range33.83 - 48.85 Perf YTD3.81%
Dividend- P/FCF80.51 EPS past 5Y9.40% ROI7.10% 52W High-15.74% Beta0.47
Dividend %- Quick Ratio10.00 Sales past 5Y7.80% Gross Margin46.10% 52W Low21.69% ATR1.10
Employees1841 Current Ratio12.00 Sales Q/Q17.40% Oper. Margin15.80% RSI (14)42.12 Volatility1.91% 2.81%
OptionableYes Debt/Eq0.00 EPS Q/Q6.10% Profit Margin12.70% Rel Volume0.60 Prev Close41.09
ShortableYes LT Debt/Eq0.00 EarningsSep 21 BMO Payout0.00% Avg Volume295.73K Price41.16
Recom2.30 SMA20-2.72% SMA50-3.52% SMA200-5.97% Volume178,286 Change0.17%
May-23-19Initiated Guggenheim Neutral
Dec-05-17Resumed ROTH Capital Neutral $82
Jul-14-17Initiated CL King Neutral
Jun-05-14Initiated William Blair Mkt Perform
Mar-31-11Upgrade Hilliard Lyons Underperform → Neutral
Sep-25-09Reiterated Roth Capital Buy $33 → $36
Jul-22-09Reiterated Roth Capital Buy $29 → $33
Mar-20-09Reiterated Roth Capital Buy $32 → $28
Jan-07-09Reiterated Roth Capital Buy $33 → $32
Sep-25-08Reiterated Roth Capital Buy $30 → $33
Jan-04-08Reiterated Roth Capital Buy $28 → $30
Sep-28-07Reiterated Roth Capital Buy $23.33 → $28
Jul-25-07Reiterated Roth Capital Buy $33 → $35
Jul-09-07Reiterated Roth Capital Buy $27 → $33
May-08-07Initiated Susquehanna Financial Positive
Oct-06-21 08:45AM  
Oct-04-21 09:49AM  
09:30AM  
Sep-29-21 10:25AM  
10:09AM  
Sep-28-21 08:45AM  
Sep-27-21 10:20AM  
Sep-23-21 12:00PM  
08:45AM  
08:20AM  
Sep-22-21 09:30AM  
Sep-21-21 08:00PM  
03:00PM  
10:35AM  
10:05AM  
08:45AM  
Sep-20-21 01:45PM  
Aug-19-21 11:30AM  
Aug-12-21 09:15AM  
Jul-28-21 08:45AM  
Jul-26-21 06:57AM  
Jul-21-21 09:01AM  
Jul-20-21 04:00PM  
10:15AM  
08:45AM  
Jul-13-21 03:00PM  
Jun-28-21 08:45AM  
Jun-25-21 07:12AM  
Jun-24-21 02:00PM  
Jun-21-21 12:49PM  
Jun-17-21 08:45AM  
Jun-10-21 05:11AM  
Jun-02-21 08:45AM  
May-12-21 09:15AM  
May-03-21 08:45AM  
Apr-22-21 11:30AM  
04:34AM  
Apr-14-21 09:40AM  
Apr-12-21 12:33PM  
Apr-06-21 10:00AM  
Mar-26-21 04:01PM  
Mar-24-21 11:06AM  
Mar-23-21 05:00PM  
10:05AM  
08:51AM  
08:45AM  
Mar-16-21 12:30PM  
Mar-08-21 11:10AM  
Mar-02-21 09:30AM  
Feb-15-21 10:00AM  
Feb-09-21 05:40AM  
Feb-01-21 08:45AM  
Jan-21-21 11:30AM  
Jan-18-21 08:41AM  
Jan-14-21 12:12PM  
Jan-13-21 10:18AM  
Jan-12-21 09:52AM  
08:45AM  
Jan-07-21 12:13PM  
Jan-06-21 01:30PM  
Jan-04-21 08:45AM  
Dec-23-20 08:42AM  
Dec-22-20 03:30PM  
12:48PM  
10:05AM  
09:15AM  
08:45AM  
Dec-21-20 04:27AM  
Dec-16-20 03:19PM  
Dec-14-20 11:46AM  
08:45AM  
Dec-08-20 08:45AM  
Nov-20-20 10:14AM  
Nov-13-20 07:07AM  
Oct-28-20 08:45AM  
Oct-22-20 12:03PM  
11:30AM  
Oct-15-20 11:30AM  
Oct-14-20 02:36PM  
Oct-08-20 09:55AM  
Oct-07-20 08:40AM  
Oct-06-20 12:45PM  
Oct-01-20 07:06PM  
Sep-23-20 09:30AM  
Sep-22-20 04:30PM  
10:05AM  
09:00AM  
08:45AM  
Sep-16-20 08:45AM  
Sep-15-20 12:30PM  
Sep-03-20 08:45AM  
Sep-02-20 11:26AM  
Sep-01-20 09:05AM  
Aug-20-20 11:30AM  
Aug-17-20 09:12AM  
Aug-13-20 08:45AM  
02:58AM  
Aug-03-20 08:45AM  
Jul-24-20 10:20AM  
Jul-22-20 10:43AM  
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lilly Jason WarrenVice PresidentSep 30Option Exercise20.2315,998323,66035,998Sep 30 06:10 PM
Quinlan Steven J.Vice President & CFOSep 30Option Exercise20.2312,964262,27940,903Sep 30 06:28 PM
Lilly Jason WarrenVice PresidentSep 30Sale43.7215,998699,45020,000Sep 30 06:10 PM
Quinlan Steven J.Vice President & CFOSep 29Option Exercise20.235,700115,31833,639Sep 30 06:28 PM
Quinlan Steven J.Vice President & CFOSep 29Sale44.055,700251,05927,939Sep 30 06:28 PM
Tobin James PDirectorSep 23Buy42.921,00042,92012,000Sep 24 05:49 PM
MORRICAL TERRI ASenior Director, Special ProjeMay 03Option Exercise62.704,184262,33741,759May 04 04:14 PM
MORRICAL TERRI ASenior Director, Special ProjeMay 03Sale97.004,184405,86037,575May 04 04:14 PM
Lilly Jason WarrenVice President, InternationalMay 03Sale96.7335033,85610,003May 04 04:04 PM
MORRICAL TERRI ASenior Director, Special ProjeApr 26Option Exercise62.7080050,16038,375Apr 27 02:26 PM
MORRICAL TERRI ASenior Director, Special ProjeApr 26Sale97.021,921186,38137,575Apr 27 02:26 PM
MORRICAL TERRI ASenior Director, Special ProjeApr 23Option Exercise62.701,12170,28738,696Apr 27 02:26 PM
Quinlan Steven J.Vice President & CFOApr 14Option Exercise60.4313,001785,61826,471Apr 14 06:18 PM
Quinlan Steven J.Vice President & CFOApr 14Sale93.9313,0011,221,15313,470Apr 14 06:18 PM
Lilly Jason WarrenVice President, InternationalApr 13Sale92.2599391,60410,353Apr 14 06:07 PM
ADENT JOHN EDWARDPresident & CEOMar 31Option Exercise63.1340,4642,554,65860,544Apr 01 09:19 PM
MORRICAL TERRI ASenior Director, Special ProjeMar 31Option Exercise55.7231,4011,749,72368,976Apr 05 06:36 PM
MORRICAL TERRI ASenior Director, Special ProjeMar 31Sale88.0331,4012,764,23037,575Apr 05 06:36 PM
ADENT JOHN EDWARDPresident & CEOMar 31Sale87.9940,4643,560,39520,080Apr 01 09:19 PM
MORRICAL TERRI ASenior Director, Special ProjeMar 29Option Exercise40.4660024,27838,175Mar 31 07:16 PM
MORRICAL TERRI ASenior Director, Special ProjeMar 29Sale87.9960052,79537,575Mar 31 07:16 PM
PAPESH BRUCEDirectorMar 25Option Exercise62.317,000436,15043,261Mar 26 03:46 PM
PAPESH BRUCEDirectorMar 25Sale85.427,000597,95736,261Mar 26 03:46 PM
Lilly Jason WarrenVice President, InternationalFeb 05Sale85.232,265193,05211,346Feb 08 02:31 PM
PAPESH BRUCEDirectorJan 13Option Exercise27.9830,000839,52066,261Jan 14 08:27 AM
PAPESH BRUCEDirectorJan 13Sale83.4030,0002,502,06336,261Jan 14 08:27 AM
Quinlan Steven J.Vice President & CFOJan 07Option Exercise40.469,333377,63722,803Jan 07 06:53 PM
ADENT JOHN EDWARDPresident & CEOJan 07Option Exercise51.2920,0001,025,85036,080Jan 08 09:24 AM
Quinlan Steven J.Vice President & CFOJan 07Sale84.499,333788,52613,470Jan 07 06:53 PM
Lilly Jason WarrenVice President, InternationalJan 06Option Exercise63.3312,600797,94024,632Jan 07 08:14 AM
Lilly Jason WarrenVice President, InternationalJan 06Sale82.9111,021913,71613,611Jan 07 08:14 AM
BOEHM WILLIAM TDirectorJan 05Option Exercise31.243,00093,72013,479Jan 06 04:19 PM
BOEHM WILLIAM TDirectorJan 05Sale80.723,000242,17110,479Jan 06 04:19 PM
Lilly Jason WarrenVice President, InternationalNov 16Option Exercise40.4616,001647,44020,932Nov 18 06:13 PM
Lilly Jason WarrenVice President, InternationalNov 16Sale73.2314,3781,052,91412,032Nov 18 06:13 PM
Quinlan Steven J.Vice President & CFONov 03Option Exercise35.346,666235,57620,136Nov 04 02:40 PM
Quinlan Steven J.Vice President & CFONov 03Sale70.546,666470,24013,470Nov 04 02:40 PM
Quinlan Steven J.Vice President & CFONov 02Option Exercise35.3480028,27214,270Nov 04 02:40 PM
Quinlan Steven J.Vice President & CFONov 02Sale70.5580056,43713,470Nov 04 02:40 PM
Lilly Jason WarrenVice PresidentOct 21Option Exercise35.346,666235,57617,075Oct 22 08:41 AM
Lilly Jason WarrenVice PresidentOct 21Sale70.626,666470,77010,409Oct 22 08:41 AM